Children's Hospital of Philadelphia (CHOP) is the first hospital in the United States devoted exclusively to the care of children. Since its start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic “firsts” in pediatric medicine. Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives, worldwide.
World-class Care
Our physicians are internationally-recognized experts in every pediatric specialty, including cancer, cardiac care, fetal medicine, orthopaedics, neonatology, endocrinology, gastroenterology and urology. Children’s Hospital is also consistently recognized as a national leader in the advancement of healthcare for children: for the 17th straight year, U.S. News & World Report ranked CHOP among the best children’s hospitals in the United States, and awarded it the elite recognition of No. 4, on its 2023-24 Honor Roll.
U.S. News also ranked the Department of Pediatrics at the University of Pennsylvania’s Perelman School of Medicine, located at CHOP, as the No. 1 Department of Pediatrics in the country by U.S. News for the last 11 years.
Innovation and Education
A critical part of CHOP’s mission to be the leader in advancing healthcare for children globally is the ability to robustly integrate novel research into the high-quality clinical care it delivers. Celebrating its 100th anniversary in 2022, Children's Hospital of Philadelphia Research Institute is one of the largest pediatric research programs in the United States with nearly $350 million in total grant funding, and over 1000 principal investigators (with active grants/protocols).
The Ontario Institute for Cancer Research (OICR) is a collaborative, not-for-profit research institute funded by the Government of Ontario. We conduct and enable high-impact translational cancer research to accelerate the development of discoveries for patients around the world while maximizing the economic benefit of this research for the people of Ontario. OICR has world-leading expertise in diverse fields such as drug discovery, genomics, immuno-oncology, informatics, molecular pathology, and implementation science. We have 590 active collaborative projects globally and we’re a founding partner of major international initiatives such as the International Cancer Genome Consortium and the Global Alliance for Genomics and Health. OICR’s strategic commercialization partner, FACIT, is an award-winning venture firm that builds companies with entrepreneurs to accelerate oncology innovations and has a portfolio that has attracted over $1.5 billion in investments to date. Together, OICR and FACIT capitalize on investments in research and healthcare to the benefit of the economy and patients worldwide.
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy.
SITC is a 501(c)(3) not-for-profit medical professional society of influential research scientists, physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere.
Currently, SITC has more than 4,650 members who represent over 35 medical specialties in 63 countries around the world.
Through emphasis on high-caliber scientific meetings; dedication to education and outreach activities; focus on initiatives of major importance in the field; and commitment to collaborations with like-minded domestic and international organizations, government and regulatory agencies, associations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community.
SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Established as a charitable, non-profit organization in 1995; Qatar Diabetes Association leads efforts in Qatar and the Middle East to promote the prevention, care, and management of diabetes.
Qatar Diabetes Association (QDA) is an active member of the International Diabetes Federation (IDF) since 1997 and is recognized by it as a “Center of Education.”
(QDA) leads efforts in Qatar and the Middle East to promote the prevention, care, and management of diabetes. The Association’s mission is to provide care for people suffering from diabetes so that they can lead full and productive lives. Through its various health-education activities and programs, QDA provides information, outreach, and support to people with diabetes and their families and raises public awareness of the causes of the condition and the means to prevent it.
For more information, please visit our website www.qda.org.qa
Hamad Bin Khalifa University (HBKU)
Innovating Today, Shaping Tomorrow
Hamad Bin Khalifa University (HBKU), a member of Qatar Foundation for Education, Science, and Community Development (QF), was founded in 2010 as a research-intensive university that acts as a catalyst for transformative change in Qatar and the region while having global impact. Located in Education City, HBKU is committed to building and cultivating human capacity through an enriching academic experience, innovative ecosystem, and unique partnerships. HBKU delivers multidisciplinary undergraduate and graduate programs through its colleges, and provides opportunities for research and scholarship through its institutes and centers. For more information about HBKU, visit www.hbku.edu.qa.
ابتكار يصنع الغد
تأسست جامعة حمد بن خليفة، عضو مؤسسة قطر للتربية والعلوم وتنمية المجتمع، عام 2010 كجامعة بحثية؛ لتساهم في تطوير دولة قطر والمنطقة بأسرها، فضلًا عن تدعيم مركزها وتأثيرها العالمي. ومن خلال موقعها في المدينة التعليمية، تلتزم جامعة حمد بن خليفة ببناء القدرات البشرية وتعزيزها، عبر التجارب الأكاديمية الثرية والمناهج المبتكرة والشراكات الفريدة. وتقدم الجامعة مجموعة من البرامج الأكاديمية متعددة التخصصات في المرحلة الجامعية وفي الدراسات العليا من خلال كلياتها، كما تُوفر الجامعة فرصًا فريدة في مجالي البحوث والمعرفة من خلال معاهدها ومراكزها البحثية. للمزيد من المعلومات عن جامعة حمد بن خليفة، يُرجى زيارة: www.hbku.edu.qa
Weill Cornell Medicine-Qatar
About Weill Cornell Medicine - Qatar
Weill Cornell Medicine - Qatar is a partnership between Cornell University and Qatar Foundation. It offers a comprehensive six-year medical program leading to the Cornell University M.D. degree with teaching by Cornell and Weill Cornell faculty and by physicians at Hamad Medical Corporation (HMC), Aspetar Orthopedic and Sports Medicine Hospital, the Primary Health Care Corporation, the Feto Maternal Center, and Sidra Medicine, who hold Weill Cornell appointments. Through its biomedical research program, WCM-Q is building a sustainable research community in Qatar while advancing basic science and clinical research. Through its medical college, WCM-Q seeks to provide the finest education possible for medical students, to improve health care both now and for future generations, and to provide high-quality health care to the Qatari population.
Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East.
For more than four decades, HMC has been dedicated to delivering the safest, most effective, and compassionate care to all its patients.
HMC manages 14 hospitals, as well as the National Ambulance Service, Mental Health Service, and home and residential care services.
HMC’s hospitals have been accredited by the prestigious Joint Commission International more than 40 times over the last 16 years, recognizing HMC’s commitment to providing the highest quality of care and safety for all patients.
YCharOS Inc. is a Canadian, public interest, open science company with the mission of characterizing commercially available antibody reagents for every human protein.
Our gold standard genetic characterization process uses both a cell line expressing adequate endogenous levels of the target protein and a CRISPR knockout version of the same cell line as a negative control.
The applications tested are immunoblot, immunoprecipitation and immunofluorescence. We are committed to following the open science principles and all our methods and results will be transparent and patent-free.
The antibody characterization methodology follows a seminal methodology formalized at the Montreal Neurological Institute. The company is wholly owned by the Agora Open Science Trust, a registered charity.
Mass General Brigham, headquartered in Boston, Massachusetts, USA, is an integrated academic healthcare system founded by Massachusetts General Hospital and Brigham and Women's Hospital. We provide the full spectrum of healthcare, from prestigious academic medical centers to local community hospitals and home care services.
Our five Harvard-affiliated research and teaching hospitals are consistently ranked among the best hospitals in the U.S. and around the world. Thousands of our physicians are Harvard Medical School faculty, teaching the next generation of healthcare leaders. Through our integrated healthcare system, patients have access to the most specialized physicians across almost every medical field.
For over 200 years, Mass General Brigham has been one of the world's most powerful engines of medical progress. Our patient-centered mentality and systemwide collaborative approach are critical to research breakthroughs that enable new treatments and improve patient outcomes. Our legacy of groundbreaking research and life-changing discoveries continues today.
Each year our dedicated care teams tirelessly deliver evidence-based care to 2.6 million patients from around the world and the United States. We specialize in complex conditions, clinical trials, advanced treatments and surgeries, providing care to patients of all ages from over 140 countries across virtually every medical specialty.
The Ministry of Public Health in Qatar is the sole authority responsible for all issues related to public health affairs in the country, supervising the provision of healthcare services in the country, providing preventive and curative health services of international reputation and global appreciation, as well as spreading and raising health awareness. It is also responsible for regulating the private sector’s establishment of health facilities and overseeing them, and supervising the health insurance system, hospitals, and primary health care centers, and the practice of medical, allied, and pharmacy professions. Moreover, The Ministry is working on developing electronic and medical strategies and capabilities, supporting an enabling system for innovative health care research, maintaining a system for preparedness and response to national health emergencies, supervising the treatment of citizens abroad, and regulating food safety issues.
The Ministry is working on developing an integrated and comprehensive healthcare system, managed according to world-class standards, with accessible health services to the entire population in line with the goals of Qatar National Vision 2030 to ensure continuous care, develop frameworks to provide healthcare services to priority populations and introduce new tools and procedures to support patient care and transfer of knowledge among different healthcare systems.
The Ministry of Public Health and its affiliated institutions (Hamad Medical Corporation, Primary Healthcare Corporation and Naufar) have achieved significant milestones; Qatar has laid the foundations to a strong global health system, and Qatar's healthcare system has seen an important development and improvement in recent decades. Investment in new health facilities, services and techniques has contributed to the overall development of the country's health sector infrastructure with a view to meeting health needs of the steadily growing population in the country, which has also helped in the success of our health system in dealing with the COVID-19 pandemic, reducing its effects, and protecting society.
G2MC is identifying opportunities to foster global collaboration to demonstrate the value and the effective use of genomics in medicine. The G2MC was started as an ‘action collaborative’ in the United States National Academies of Medicine and was also supported by the National Human Genome Research Institute of the NIH. Now, as an independent not-for-profit charitable organization, it seeks to improve global health by catalyzing the implementation of genomic tools and knowledge into healthcare delivery globally.
Gulf Scientific Corporation (GSC) was established with a mission to inspire scientific research. A leading provider of life, material and analytical science solutions throughout the Middle East & North Africa, GSC has been a guiding force in the scientific communities across the region. Our unrivaled support structure is centered around innovative technologies, education, training and service, making GSC a trusted choice for research and diagnostic customers alike.
By adopting a systems’ approach, as well as strategically partnering with leading technology providers, GSC offers complete laboratory solutions ranging from lab water to material testing, and from molecular and cell biology studies to in vivo imaging of animal models. GSC caters for a wide range of industries including education, pharmaceutical, food and beverage, clinical and research, and oil and gas. Our esteemed partners include Merck, Waters, PerkinElmer, Chromsystems, DNA Script, Thermo Fisher, Asuragen and Luminex. Visit https://gulf-scientific.com/
Sedeer Medical
Sedeer Medical is a total solution provider and distributor of healthcare, research, forensics, veterinary, diagnostics, life science, emergency medical services, food safety, educational institutions, oil and gas industries, environment, lab & industrial chemicals, security, IT solutions, technical support, application, training, etc. We are specialized in diversified Life Science and diagnostics segments in Qatar. Our product portfolio provides end-to-end solutions for every aspect of human life and the environment that surrounds you. Since 2001, our vision has been to pioneer in the realms of Healthcare and Laboratory Technologies by way of customer-centricity. 1 to 187 employees in a span of two decades. Achieved durable and fruitful partnerships with world-class companies to deliver top-notch technological solutions, generating high praise among customer circle. Today, we house 100+ brands and are known for our ‘specific’ solutions, dedicated services, and unbeatable customer care. Our Motto – Adding Life to dream Our Mission - Caring and striving for Healthier world by “Executing Commitments” Our Vision - Every Human has the right to great health and Quality Life
As one of Qatar’s leading healthcare solution providers, MedTech has consistently pushed the envelope when it comes to our offerings and service. The last forty years tell a story of how our success has been scripted by our core values and relentless pursuit of innovation. We render our services and supply world-class equipment to government and healthcare institutions across Qatar and the Middle East. With an ever-evolving healthcare industry, our core focus has always been to stay a step ahead of the curve. By partnering with the most premium equipment manufacturers from around the world, we deliver the future of the industry to our clients today.
Besides our world-class technology offerings, our focus on client satisfaction truly enhances the MedTech edge. By recruiting and training the best talent in the industry, we have built a team that goes above and beyond the call of duty to deliver excellence. Take for example our 24/7 support, our focus on compassionate service, and our excellent project outcomes.
Step into the world of MedTech today, and truly experience the MedTech edge.
Established in 1989, Zahrawi Group is one of the leading and pioneer Healthcare Solutions and Analytical Lab providers specializing in Surgical, Medical, Nuclear Medicine, and Diagnostic and Analytical labs. Founded in Dubai, U.A.E, Zahrawi Group has an emphatic presence across the G.C.C. with its own operations in the U.A.E., Saudi Arabia, Qatar, Bahrain, and Oman.
Throughout the years, Zahrawi Group has made its mission to introduce an extensive range of high-quality and advanced technology products to the Middle East market, enabling doctors and patients to access the best in terms of Healthcare.
Our portfolio includes more than 200 international world-renowned manufacturers, including but not limited to Medtronic, Bariatric Solutions, Fitforme, Smith & Nephew, Fujifilm, NuVasive, Hitachi, H.U.R., Biodex, Hocoma, Johnson & Johnson Vision, Geuder, Linet, Laborie, Polatom, Sirtex, CIVCO, B.D., Sysmex, Sebia, Agilent Technologies, Cepheid, Sakura.
We take pride in our representation that includes an extensive profile of internationally renowned Healthcare and Laboratory manufacturers, such as Medtronic, Agilent Technologies, Dako, Sakura, B.D., Sysmex, Cepheid, Hitachi, Sebia, and many others.
Thanks to our trained engineers, we respond to our customer's needs in a manner that meets their requirements and delivers the products and services on time with reliable after-sales support. Capitalizing on excellent staff with high ethics and a robust operation support platform, we continue to have sustainable growth year over year. In 2020, we achieved Dhs 583 Million in revenues. By 2023, we are looking forward to reaching the S.A.R. 1 Billion milestone as per our growth plan.
Zahrawi Group is continuously expanding, progressing, and contributing to the prosperity of the people and economy of the region.
Qatar Scientific Company takes immense pride in its diverse and comprehensive portfolio, meticulously designed to cater to the evolving needs of the scientific community. Established in 2005, we have emerged as a formidable presence in Qatar, renowned for delivering exceptional products and integrated solutions across a spectrum of critical sectors.
Our commitment to excellence is unwavering, demonstrated through our partnership with globally recognized market leaders. Whether in Analytical Proteomics, Metabolomics, Genomics, Life Science Diagnostics, or Informatics, we offer top-notch tools and services. We prioritize after-sale support with a dedicated team comprising Technical Support, Service Engineers, and Administration Staff.
What sets us apart is our customer-centric approach. We invest time in understanding your specific requirements and offer comprehensive Genomic, Life Science, & Analytical solutions. This includes not only exceptional products but also training and application support.
At Qatar Scientific, we believe in providing holistic solutions to empower your research and clinical endeavors.
Qatar Scientific Company is proud to partner with MGI Tech Co., Ltd. (MGI) for this event. This collaboration brings together the expertise of Qatar Scientific Company and the innovative technology of MGI, creating a synergy that enhances the value we offer to our customers.
MGI Corporate Overview
MGI Tech Co., Ltd. (MGI) is committed to building core tools and technology to lead life science through intelligent innovation. With a focus on R&D, production, and sales of DNA sequencing instruments, reagents, and related products, MGI provides real-time, panoramic, and life course equipment and systems for precision medicine, precision agriculture, precision healthcare, and other relevant industries. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation.
As of June 30, 2023, MGI has more than 2,800 employees, 35.2% of whom are R&D personnel. Founded in 2016, MGI operates in more than 90 countries and regions, serving more than 2,400 customers. It has established scientific research and production bases and a global training and service network in many countries and regions around the world. MGI is one of the few companies in the world that can independently develop and mass-produce low-, medium-, and high-throughput clinical gene sequencers from GB to TB. Providing real-time, comprehensive, life course solutions, its vision is to lead life science innovation.
MGI Tech Co., Ltd. (MGI) is committed to building core tools and technology to lead life science through intelligent innovation. With a focus on R&D, production, and sales of DNA sequencing instruments, reagents, and related products, MGI provides real-time, panoramic, and life course equipment and systems for precision medicine, precision agriculture, precision healthcare, and other relevant industries. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation.
As of June 30, 2023, MGI has more than 2,800 employees, 35.2% of whom are R&D personnel. Founded in 2016, MGI operates in more than 90 countries and regions, serving more than 2,400 customers. It has established scientific research and production bases and a global training and service network in many countries and regions around the world. MGI is one of the few companies in the world that can independently develop and mass-produce low-, medium-, and high-throughput clinical gene sequencers from GB to TB. Providing real-time, comprehensive life course solutions, its vision is to lead life science innovation.
Al Obeidly Trading Technology is one of the leading suppliers in Qatar, engaged in a wide range of Medical, Scientific, and Technology activities that touch the most basic and far-advanced aspects of the Health and Education Sector since 1978. The company deals with high-quality medical, scientific, educational, laboratory equipment, and research laboratory equipment. Many hospitals, laboratories, research centers, and educational institutions in Qatar are equipped with our top-quality range of sophisticated medical & laboratory equipment and educational & scientific Instruments. As an exclusive distributor of Zeiss Germany, Al Obeidly Trading Technology distributes the complete range of products manufactured by Zeiss in Qatar. We have a well-qualified and experienced team of advisory, service, and application support staff to ensure proper working and round‐the‐clock availability of equipment supplied by us.
Vital Health Technologies trading L.L.C is one of the premier medical, laboratory, and IT solution provider in Qatar. Established in 2015, we differentiate ourselves by providing outstanding local support for healthcare and clinical research organizations to achieve their organizational goals. VHT represents global brands like Fujifilm, Randox, Stemcell Technologies, Heidelberg Engineering, Nihon Kohden, Corning, Medinfo, Copan, Certest Biotech and more. Our team encompasses directors, sales and finance professionals, biomedical and IT engineers, application scientist, admin supports and logistic staffs who are committed to assure delightful customer experience on each enquiry. We are working intensively to discover pioneering solutions from reputed manufacturers that can reduce the total turnaround time with the highest level of sensitivity and specificity to improve the quality of patient results. VHT excels by outperforming the customers' expectations on aftersales support, delivery, and supply chain management.
Qatar Cancer Society is a charity that was founded in 1997. It works under the Regulatory Authority for Charitable Activities.
Our Vision
To be the community partnership platform to make Qatar a leader in cancer prevention and its burden control.
Our Mission
We seek to prevent cancer and reduce its burden in Qatar by working with our partners to educate the community, support, empower, and advocate for people living with the disease, and engage in professional development and scientific research in cancer.
New Concept Pharma, we are much more than just a distributor - we are your comprehensive partner for all your needs in healthcare, research, veterinary care, diagnostics, life sciences, laboratory sciences, food safety, technical support, applications, and training. With a relentless commitment to excellence, we have earned the trust and credibility of both the healthcare industry and our valued customers. Our unwavering presence in the healthcare landscape has solidified our position as a powerful partner for some of the world's leading healthcare brands. Like Oxford Nanopore Technologies, Euroimmun, Omixon, Better You, Elga, etc.
We are driven by the desire for long-term growth and value for our customers, constantly transforming innovation into practical solutions. We take immense pride in our role as a conduit between the world's foremost medical manufacturers and discerning customers. Our distribution model is designed for your convenience, offering unwavering support, timely delivery of top-quality equipment, and periodic servicing. Our team of highly qualified engineers collaborates closely with each manufacturer's technical support team, guaranteeing round-the-clock excellence in service.
With over 20 years’ experience, Future Health Biobank is one of the world’s largest and most accredited stem cell banks, storing over 200,000 stem cell samples for over 100,000 families. Parents can choose to store the stem cells found in the umbilical cord blood, cord tissue and dental pulp; giving families the peace-of-mind that they have access to cells that are a 100% match for their child. The stem cells found in umbilical cord blood can be used in up to 85 standard treatments for illnesses including some cancers and anaemias. Not only do we provide cutting edge stem cell technology, but we also provide genetic screening services allowing you to glimpse into your child’s future health.
Children's Hospital of Philadelphia (CHOP) is the first hospital in the United States devoted exclusively to the care of children. Since its start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic “firsts” in pediatric medicine. Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives, worldwide.
World-class Care
Our physicians are internationally-recognized experts in every pediatric specialty, including cancer, cardiac care, fetal medicine, orthopaedics, neonatology, endocrinology, gastroenterology and urology. Children’s Hospital is also consistently recognized as a national leader in the advancement of healthcare for children: for the 17th straight year, U.S. News & World Report ranked CHOP among the best children’s hospitals in the United States, and awarded it the elite recognition of No. 4, on its 2023-24 Honor Roll.
U.S. News also ranked the Department of Pediatrics at the University of Pennsylvania’s Perelman School of Medicine, located at CHOP, as the No. 1 Department of Pediatrics in the country by U.S. News for the last 11 years.
Innovation and Education
A critical part of CHOP’s mission to be the leader in advancing healthcare for children globally is the ability to robustly integrate novel research into the high-quality clinical care it delivers. Celebrating its 100th anniversary in 2022, Children's Hospital of Philadelphia Research Institute is one of the largest pediatric research programs in the United States with nearly $350 million in total grant funding, and over 1000 principal investigators (with active grants/protocols).
Integrated Gulf Biosystems (IGB) started with a mission to provide complete workflow solutions to life science customers, backed by quality service and support. Founded in 1999, IGB emerges as a leading supplier of life science tools to the Middle East, North African, and Indian regions. IGB takes pride in providing the science for a better quality of living. IGB has differentiated itself by providing end-to-end workflow solutions in Molecular and genomic solutions for Human Genetics, Human Identification, and Inherited and infectious disease diagnostics space.
The experience and expertise, coupled with its commitment, laid a strong foundation for IGB’s growth and expansion in Saudi Arabia, UAE, Bahrain, Qatar, Oman, Iraq, Libya, and India. The organization has retained its core values of expertise in delivering excellence, in the markets the company has operated for the past 25 years. The company primarily aims at improving health and safety by delivering solutions from the best technology partners and brands of the world, including Applied Biosystems & Invitrogen, a Thermo Fisher Scientific Brand, Hamilton Robotics, Element Bioscience, Angle PLC, GenDx, Agilent, Lexogen, Genetic Signatures, Menarini Silicon Biosystems etc.
In Qatar, we represent Hamilton (Robotics & Storage), Element Biosciences, Genetic Signatures, Menarini Silicon Biosystems, Lexogen, LGC Seracare, Angle PLC, Ikonisys, Bioer, Enzo Lifesciences, etc. We have a well-experienced team stationed in Doha to handle sales and after-sales requirements.
Ophir Healthcare Solutions W.L.L established in 2010 is one of the leading business houses and a total solution provider in Qatar, in the field of medical/hospital equipment industry with experienced and knowledgeable professionals with efficient support services on board! Our activities spread into Laboratory (IVD, Life science including Precision Medicine, Genomics, Stem Cell Therapy, Research, Veterinary and Analytical), Hyperbaric Oxygen Chambers, Dermatology, ENT, Ophthalmology, Physiotherapy, Operating Rooms, ICU, Oby/Gyn, NICU, Orthopedics, Neurosurgery, Medical Furniture, Sports Medicine, Accident Emergency. Ophir's goal is to provide its customers with the best options possible by staying ahead of new trends in the healthcare industry.
Profile: Founded in 2000, SomaLogic is a global leader in proteomics. Powered by an industry-leading technology platform and one of the largest clinical proteomic databases in the world, we aim to revolutionize precision medicine to help address unmet medical needs.
SomaLogic’s pioneering platform provides more coverage of the proteome than any other technology. SomaLogic currently measures approximately 7,000 proteins, more than twice as many as other proteomic technology platforms, and we are quickly moving toward 10,000 proteins. That’s half of the approximately 20,000 proteins in your body.
By understanding the intricacies of what goes on in our bodies, we strive to relieve human suffering and ultimately prolong human life.
The AGBL group of companies is the largest biomedical distribution group in the emerging markets of the Middle East, Africa, and Asia region. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic centers in emerging healthcare markets.
The AGBL Group employs a team of product and commercial specialists and has more than 18 offices across the regions: offering distribution, consulting, and product development services to manufacturers of biomedical technologies. The group’s stated mission is to improve the lives of the region’s inhabitants through novel biomedical technologies and products.
